Exchange: NYSEMkt·Updated 07:08 AM EDT
MAIA logo

MAIAMAIA Biotechnology Inc

$1.33
$0.00
(0.00%)
Pre-Market
Prev Close $1.33
Reported EarningsAug 5
Mkt Cap$77.82M
Vol55.00
News
all
press releases
$207B Market Shift: The Race for Fast Track Approval in Oncology
$207B Market Shift: The Race for Fast Track Approval in Oncology $207B Market Shift: The Race for Fast Track Approval in Oncology PR Newswire VANCOUVER, BC, Feb. 5, 2026 Issued on behalf of...
PR Newswire
MAIA’s New Agreement With Big Pharma Roche Turns Retail Investors Bullish As Stock Soars
The agreement aims to support future studies investigating the combination of MAIA’s Ateganosine and Roche’s checkpoint inhibitor, Atezolizumab, for safe and effective cancer treatments.
Stocktwits
<
...
1
>

Advertisement|Remove ads.